Cervicovaginal fetal fibronectin testing in threatened preterm labour - Translating research findings into clinical practice

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 38, Issue 4, 1998, Pages 399-402

  Chuileannain, Fiona Ni ^a   Bell, Robin ^a   Brennecke, Shaun ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FIBRONECTIN;

ADULT; ARTICLE; CLINICAL PRACTICE; DELIVERY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL RESEARCH; PREDICTION; PREMATURE LABOR; PRIORITY JOURNAL; TOCOLYSIS;

EID: 3042854504     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.1998.tb03096.x     Document Type: Article

References (12)

1. Parker J, Bell R, Brennecke S. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks' gestation. Aust NZ J Obstet Gynaecol 1995; 35: 257-261.
2. Morrison J. Preterm birth: A puzzle worth solving. Obstet Gynecol 1990, 76: 5S-10S.
3. Lockwood CJ. Senyei AE. Dische MR et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991; 325: 669-674.
4. Morrison JC, Albert JR, McLaughlin BN, Whitworth NS, Roberts WE, Martin RW. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1993; 168: 538-542.
5. Lams JD, Casal D. McGregor JA et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995, 52: S1-S12.
6. Bartnicki J, Casal D, Kreaden US, Saling E, Vetter K. Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birth-weight infants. Am J Obstet Gynecol 1996; 174. 971-974.
7. Malak TM, Sizmur F, Bell SC, Taylor DJ. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth. Br J Obstet Gynaecol 1996; 103: 648-653.
8. Ascarelli MH, Morrison JC. The use of fetal fibronectin in clinical practice. Obstet Gynecol Survey 1997; 52: S1-S12.
9. Chien PFW. Khan KS. Ogston S, Owen P. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery : an overview Br J Obstet Gynaecol 1997, 104: 436-444.
10. Lukes AS, Thorp JM, Eucker B, Pahel-Short L. Predictors of positivity for fetal fibronectin in patients with symptoms of preterm labor. Am J Obstet Gynecol 1997; 176: 639-641.
11. Peaceman AM, Andrews WW, Thorp JM et al. Fetal fibronectin as a predictor of preterm births in patients with symptoms. A multicenter trial. Am J Obstet Gynecol 1997; 177: 13-18.
12. Watson DL, Kim SJ, Humphrey MD. Study of cervicovaginal fetal fibronectin status as a guide to treatment of threatened preterm labour. Aust NZ J Obstet Gynaecol 1998; 38: 185-187.